Literature DB >> 20363919

ASIP Outstanding Investigator Award Lecture. New approaches to the pathology and genetics of neurodegeneration.

Mel B Feany1.   

Abstract

The pathologies of major neurodegenerative diseases including Parkinson disease and Alzheimer disease have been well known for decades. More recently, advances in molecular genetics have suggested important mechanistic links between the pathology of these disorders and pathogenesis of neuronal dysfunction and death. Numerous animal models have been produced based on the new information emerging from human genetic studies. As a complement to traditional mouse models, a number of investigators have modeled neurodegenerative diseases in simple model organisms ranging from yeast to Drosophila. These simple genetic models often display remarkable pathological similarities to their cognate human disorders, and genetic and biochemical studies have yielded important insights into the pathogenesis of the human disorders. Use of these tractable simple models may become even more important as large amounts of genetic data emerge from genome-wide association studies in Alzheimer disease, Parkinson disease, and other neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363919      PMCID: PMC2861071          DOI: 10.2353/ajpath.2010.091077

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  100 in total

1.  A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly.

Authors:  B I Giasson; I V Murray; J Q Trojanowski; V M Lee
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

2.  Pharmacological prevention of Parkinson disease in Drosophila.

Authors:  Pavan K Auluck; Nancy M Bonini
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

3.  Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.

Authors:  Pavan K Auluck; H Y Edwin Chan; John Q Trojanowski; Virginia M Y Lee; Nancy M Bonini
Journal:  Science       Date:  2001-12-20       Impact factor: 47.728

4.  Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment.

Authors:  Paul J Muchowski; Ke Ning; Crislyn D'Souza-Schorey; Stanley Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

5.  alpha-Synuclein is phosphorylated in synucleinopathy lesions.

Authors:  Hideo Fujiwara; Masato Hasegawa; Naoshi Dohmae; Akiko Kawashima; Eliezer Masliah; Matthew S Goldberg; Jie Shen; Koji Takio; Takeshi Iwatsubo
Journal:  Nat Cell Biol       Date:  2002-02       Impact factor: 28.824

6.  Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.

Authors:  Deniz Kirik; Carl Rosenblad; Corinna Burger; Cecilia Lundberg; Teit E Johansen; Nicholas Muzyczka; Ronald J Mandel; Anders Björklund
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

7.  alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.

Authors:  C Lo Bianco; J-L Ridet; B L Schneider; N Deglon; P Aebischer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

8.  Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.

Authors:  Michael K Lee; Wanda Stirling; Yanqun Xu; Xueying Xu; Dike Qui; Allen S Mandir; Ted M Dawson; Neal G Copeland; Nancy A Jenkins; Don L Price
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

9.  Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

Authors:  Benoit I Giasson; John E Duda; Shawn M Quinn; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal:  Neuron       Date:  2002-05-16       Impact factor: 17.173

10.  Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila.

Authors:  George R Jackson; Martina Wiedau-Pazos; Tzu-Kang Sang; Naveed Wagle; Carlos A Brown; Sasan Massachi; Daniel H Geschwind
Journal:  Neuron       Date:  2002-05-16       Impact factor: 17.173

View more
  2 in total

1.  Drosophila melanogaster: a new model to study cisplatin-induced neurotoxicity.

Authors:  Jewel L Podratz; Nathan P Staff; Dara Froemel; Anna Wallner; Florian Wabnig; Allan J Bieber; Amy Tang; Anthony J Windebank
Journal:  Neurobiol Dis       Date:  2011-04-15       Impact factor: 5.996

Review 2.  Frontotemporal dementia: implications for understanding Alzheimer disease.

Authors:  Michel Goedert; Bernardino Ghetti; Maria Grazia Spillantini
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.